The company announced a $350 million public offering on Monday shortly after revealing positive Phase II results for its ...
The MAHA movement claims wins ā fewer processed foods and seed oils, more beef and dairy products ā as Kennedy discards 421 ...
Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat, very early ...
Lines died from drug withdrawal in the Las Colinas womenās jail in May, a day after her arrest. Dean, who suffered from ...
Stocktwits on MSN
Why did Omeros stock jump 5% in after-hours trading today?
The company set a $36,000 per-vial price for Yartemlea and confirmed the start of its U.S. launch. ć»Typical Yartemlea ...
China NMPA grants marketing approval for ArkBioās Azstarys for the treatment of ADHD: Shanghai, China Wednesday, January 7, 2026, 16:00 Hrs [IST] Shanghai Ark Biopharmaceutical ...
This weekās "Casting Call with Tess Hammock" features a featured role on a hit TV series, unique background casting for All ...
Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...
Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera
Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...
Investor's Business Daily on MSN
Eli Lilly, IBD stock of the day, offers two entries on rumored buyout rally
Eli Lilly is Wednesday's IBD Stock Of The Day. Shares are breaking above a pair of bases as rumors swirl about a potential ...
Independent Analysis Addresses Common Consumer Questions Including Legitimacy, Safety Considerations, Pricing Transparency, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback